-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Opsens Inc. (TSE:OPS) Expected to Post FY2025 Earnings of $0.02 Per Share
Opsens Inc. (TSE:OPS) Expected to Post FY2025 Earnings of $0.02 Per Share
Opsens Inc. (TSE:OPS – Get Rating) – Equities researchers at Raymond James reduced their FY2025 EPS estimates for shares of Opsens in a research report issued on Wednesday, September 7th. Raymond James analyst R. Sarugaser now anticipates that the company will earn $0.02 per share for the year, down from their prior forecast of $0.03. Raymond James currently has a "Buy" rating and a $6.00 target price on the stock. The consensus estimate for Opsens' current full-year earnings is ($0.06) per share.
Get Opsens alerts:Opsens (TSE:OPS – Get Rating) last released its earnings results on Thursday, July 14th. The company reported C($0.03) earnings per share for the quarter, missing analysts' consensus estimates of C($0.02) by C($0.01). The firm had revenue of C$10.08 million for the quarter, compared to analysts' expectations of C$8.65 million.
Opsens Stock Down 1.4 %
Opsens stock opened at C$2.74 on Friday. Opsens has a twelve month low of C$1.55 and a twelve month high of C$3.74. The firm has a 50 day moving average price of C$2.55 and a 200-day moving average price of C$2.19. The company has a market capitalization of C$298.03 million and a P/E ratio of -46.44. The company has a quick ratio of 4.88, a current ratio of 5.87 and a debt-to-equity ratio of 18.46.About Opsens
(Get Rating)
Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.
Featured Stories
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.
Opsens Inc. (TSE:OPS – Get Rating) – Equities researchers at Raymond James reduced their FY2025 EPS estimates for shares of Opsens in a research report issued on Wednesday, September 7th. Raymond James analyst R. Sarugaser now anticipates that the company will earn $0.02 per share for the year, down from their prior forecast of $0.03. Raymond James currently has a "Buy" rating and a $6.00 target price on the stock. The consensus estimate for Opsens' current full-year earnings is ($0.06) per share.
Opsens Inc.(TSE：OPS-GET Rating)-在9月7日星期三發佈的一份研究報告中，Raymond James的股票研究人員下調了對Opsens股票的2025財年每股收益預期。Raymond James分析師R.Sarugaser現在預計，該公司今年的每股收益將為0.02美元，低於此前預測的0.03美元。雷蒙德·詹姆斯目前對該股的評級為買入，目標價為6.00美元。對Opsens目前全年收益的普遍估計是每股0.06美元。
Opsens (TSE:OPS – Get Rating) last released its earnings results on Thursday, July 14th. The company reported C($0.03) earnings per share for the quarter, missing analysts' consensus estimates of C($0.02) by C($0.01). The firm had revenue of C$10.08 million for the quarter, compared to analysts' expectations of C$8.65 million.
Opsens(東京證券交易所股票代碼：OPS-GET Rating)最近一次發佈財報是在7月14日(星期四)。該公司公佈本季度每股收益為0.03加元，低於分析師普遍預期的0.02加元(0.01美元)。該公司本季度營收為1,008萬加元，高於分析師預期的865萬加元。
Opsens Stock Down 1.4 %
Opsens股價下跌1.4%
About Opsens
關於奧普森
(Get Rating)
(獲取評級)
Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.
Opsens Inc.開發、製造、安裝和銷售用於介入心臟病學、部分血流儲備(FFR)、石油和天然氣以及工業應用的光纖傳感器。該公司在醫療和工業兩個領域開展業務。醫療部門主要專注於生理測量，如冠狀動脈狹窄市場的FFR和DPR；並提供一系列微型光學傳感器，用於測量其他醫療設備中的集成應用中的壓力和温度，並獲得其光學傳感器技術的許可。
Featured Stories
專題報道
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- MarketBeat：回顧一週9/5-9/9
- 為網絡安全股創紀錄的季度做準備
- 汽車市場正在緩慢復甦，這些股票可能表現優異
- DocuSign是否即將發生重大逆轉？
- 石油和天然氣股票：投資可再生能源的安全途徑
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.
接受Opsens Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Opsens和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧